Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma

NCT07655570 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Angiosarcoma

Interventions

DRUG: Ivonescimab

Sponsor

M.D. Anderson Cancer Center